Arie H. Bartal
About
In The Last Decade
Arie H. Bartal
37 papers receiving 278 citations
Peers
Comparison fields: 5 of 66
- Oncology 118
- Molecular Biology 82
- Radiology, Nuclear Medicine and Imaging 74
- Immunology 65
- Surgery 52
Countries citing papers authored by Arie H. Bartal
This map shows the geographic impact of Arie H. Bartal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arie H. Bartal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arie H. Bartal more than expected).
Fields of papers citing papers by Arie H. Bartal
This network shows the impact of papers produced by Arie H. Bartal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arie H. Bartal. The network helps show where Arie H. Bartal may publish in the future.
Co-authorship network of co-authors of Arie H. Bartal
This figure shows the co-authorship network connecting the top 25 collaborators of Arie H. Bartal. A scholar is included among the top collaborators of Arie H. Bartal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arie H. Bartal. Arie H. Bartal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 10 | |
| 8 | Monoclonal antibodies alter granulocyte function | 1 |
| 9 | 23 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 4 | |
| 15 | 3 | |
| 16 | Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER). | 7 |
| 17 | 4 | |
| 18 | 17 | |
| 19 | 6 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.